
Baby Aspirin Use for Heart Prevention Drops Significantly as Guidelines Tighten
A Epic Research analysis of about 279 million primary-care visits (2015–2025) shows daily low-dose aspirin use for preventing cardiovascular disease has roughly halved, dropping from about 7% in 2018 to 3% by 2025; guideline changes over the past decade discourage aspirin for primary prevention in favor of managing risk factors like cholesterol and blood pressure, while aspirin may still help for people who have already had a heart attack, stroke, or a stent, after individualized risk assessment.













